New lens design aims for better stability after cataract surgery

NCT ID NCT07167589

Completed Knowledge-focused Sponsor: Vienna Institute for Research in Ocular Surgery Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a new type of artificial lens (HOYA AF-1 NY-60) used during cataract surgery. The lens is designed to stay in place better and reduce clouding behind the lens. Researchers looked at how well the lens performed in 42 people with normal, short, or long eyes. The study is complete and focused on lens positioning and stability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: single-piece hydrophobic acrylic intraocular lens (IOL)
What this could lead to: If successful, this lens design could reduce complications like posterior capsule opacification and improve stability after cataract surgery.
What could go wrong: This is a small, completed study with only 42 participants, so results may not apply to all patients. No direct comparison to other lenses was made.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract senile cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT SURGERY, SINGLE-PIECE IOL, MICROINCISIONAL IOL

Contacts and locations

Show contact details

Locations

Vienna Institute for Research in Ocular Surgery

Vienna, 1140, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.